Fostamatinib 100 mg [clinicaltrials_resource:52b03f974ea2b24e6316a1bea1cd0c0d]
intervention [clinicaltrials_vocabulary:intervention]
Fostamatinib 100 mg [clinicaltrials_resource:52b03f974ea2b24e6316a1bea1cd0c0d]
Bio2RDF identifier
52b03f974ea2b24e6316a1bea1cd0c0d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:52b03f974ea2b24e6316a1bea1cd0c0d
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Fostamatinib 100 mg tablet twice daily by mouth, over the course of 24 weeks
intervention name [clinicaltrials_vocabulary:intervention-name]
Fostamatinib 100 mg
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:52b03f974ea2b24e6316a1bea1cd0c0d
title
Fostamatinib 100 mg
@en
type
label
Fostamatinib 100 mg [clinicaltrials_resource:52b03f974ea2b24e6316a1bea1cd0c0d]
@en